The global fluorescence guided surgery system market size accounted for USD 112 million in 2024 and is expected to exceed around USD 477.31 million by 2034, growing at a CAGR of 15.6% from 2024 to 2034.
Fluorescence Guided Surgery System Market is the market for advanced imaging systems utilized during the operation to distinguish and visualize tissues with the help of fluorescent dyes. The global market is poised to grow because of the rising healthcare expenditure, regulatory approvals, and growing prevalence of targeted surgical procedures. Fluorescence-guided surgery improves patient outcomes by optimizing its adoption in healthcare organizations. Fluorescence-guided surgery is set to improve precision during surgery and will enhance patient outcomes.
The surging need for minimally invasive surgical procedures is the latest trend in the market that boosting the adoption of these systems. FGS systems can minimize damage, visualize target tissues, and also improve patient outcomes during the process. Furthermore, an increasing number of surgeries for targeted disorders such as cardiovascular disease and cancer is anticipated to propel the fluorescence-guided surgery system market soon.
Published by Ajit Bansod
